chrX-118392642-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM1BP4_StrongBS2
The NM_019045.5(WDR44):c.197G>T(p.Ser66Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000471 in 1,188,396 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 26 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000051 ( 0 hom. 26 hem. )
Consequence
WDR44
NM_019045.5 missense
NM_019045.5 missense
Scores
2
3
12
Clinical Significance
Conservation
PhyloP100: 6.39
Genes affected
WDR44 (HGNC:30512): (WD repeat domain 44) This gene encodes a protein that interacts with the small GTPase rab11. A similar protein in rat binds the GTP-containing active form of rab11. This protein may play a role in endosome recycling. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
PM1
In a modified_residue Phosphoserine (size 0) in uniprot entity WDR44_HUMAN
BP4
Computational evidence support a benign effect (MetaRNN=0.039993882).
BS2
High Hemizygotes in GnomAdExome4 at 26 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WDR44 | NM_019045.5 | c.197G>T | p.Ser66Ile | missense_variant | 4/20 | ENST00000254029.8 | |
WDR44 | NM_001184965.2 | c.197G>T | p.Ser66Ile | missense_variant | 4/20 | ||
WDR44 | NM_001184966.1 | c.122G>T | p.Ser41Ile | missense_variant | 3/18 | ||
WDR44 | XM_011531353.4 | c.122G>T | p.Ser41Ile | missense_variant | 3/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WDR44 | ENST00000254029.8 | c.197G>T | p.Ser66Ile | missense_variant | 4/20 | 1 | NM_019045.5 | P1 | |
WDR44 | ENST00000371825.7 | c.197G>T | p.Ser66Ile | missense_variant | 4/20 | 1 | |||
WDR44 | ENST00000371822.9 | c.122G>T | p.Ser41Ile | missense_variant | 3/18 | 2 | |||
WDR44 | ENST00000493448.1 | n.468G>T | non_coding_transcript_exon_variant | 3/3 | 4 |
Frequencies
GnomAD3 genomes AF: 0.00000893 AC: 1AN: 111976Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34152
GnomAD3 genomes
AF:
AC:
1
AN:
111976
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34152
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000138 AC: 23AN: 167089Hom.: 0 AF XY: 0.000123 AC XY: 7AN XY: 56903
GnomAD3 exomes
AF:
AC:
23
AN:
167089
Hom.:
AF XY:
AC XY:
7
AN XY:
56903
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000511 AC: 55AN: 1076420Hom.: 0 Cov.: 29 AF XY: 0.0000746 AC XY: 26AN XY: 348758
GnomAD4 exome
AF:
AC:
55
AN:
1076420
Hom.:
Cov.:
29
AF XY:
AC XY:
26
AN XY:
348758
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000893 AC: 1AN: 111976Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34152
GnomAD4 genome
AF:
AC:
1
AN:
111976
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34152
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
22
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 25, 2024 | The c.197G>T (p.S66I) alteration is located in exon 4 (coding exon 4) of the WDR44 gene. This alteration results from a G to T substitution at nucleotide position 197, causing the serine (S) at amino acid position 66 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;L
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Benign
T;D;D
Polyphen
0.51, 0.65
.;P;P
Vest4
MutPred
0.26
.;Loss of phosphorylation at S66 (P = 0.0221);Loss of phosphorylation at S66 (P = 0.0221);
MVP
MPC
0.34
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at